Marketing Pharmaceutical Products in CIS/Eurasian Economic Union
The interest of pharmaceutical companies in expanding business across the Commonwealth of Independent States (CIS) and the Eurasian Economic Union (EAEU) has been constantly growing. For the same reason, Biomapas provides end-to-end regulatory support in these...
Partial Pharmacovigilance Outsourcing: A Scalable Approach for Biopharma
Partial pharmacovigilance outsourcing offers biopharmaceutical companies a flexible way to stay compliant without committing to a full-service model. By outsourcing high-volume pharmacovigilance activities they can’t efficiently manage in-house, such as case...
Pharmacovigilance and Medical Information Outsourcing: Benefits for Biotech
Pharmacovigilance (PV) and medical information (MI) are complementary components of an effective compliance framework. While they serve distinct operational roles, strong coordination between them supports consistent safety management across the product...
Comprehensive Guide to Medical Information and Pharmacovigilance Integration
Is medical information (MI) and pharmacovigilance (PV) integration still optional? The short answer is no. Regulators expect every enquiry, report, and safety update to connect seamlessly. When these functions work in isolation, gaps appear, and those gaps create...
